CALABASAS, Calif., Feb. 9, 2006 (PRIMEZONE) -- Aspyra, Inc. (AMEX:APY), a global provider of Health Care Information Technology (HCIT) diagnostic data management and systems for the healthcare industry, today announced that it has appointed The Wall Street Group, Inc. as its financial public relations advisor.
"With our recently completed merger and name change to Aspyra, Inc., we believe the timing is right to bring the business opportunities created by the newly formed company to the attention of professional investors," stated President and Chief Executive Officer Steven M. Besbeck. Aspyra was recently formed by the merger of Creative Computer Applications, Inc. (formerly AMEX:CAP), a provider of Clinical Information Systems (CIS) and privately held StorCOMM, Inc., a leader in Picture Archive Communications Systems (PACS). "The Wall Street Group's excellent reputation within the financial community will enable our company to increase investor awareness and visibility, particularly among institutional investors," said Mr. Besbeck.
The Wall Street Group, based in New York City, was founded in 1959 and is the oldest firm of its kind specializing in developing investment community sponsorship for the shares of growth companies. The firm will concentrate on introducing Aspyra to brokers, analysts, money managers, institutional investors and investment bankers.
About Aspyra, Inc.
Aspyra is a global provider of clinical and diagnostic information solutions for the healthcare industry. We have accumulated over 35 years of industry experience, specializing in enterprise-wide systems for hospitals, multi-specialty clinics, clinical laboratories, imaging departments and centers, orthopedic environments and pharmacies. Our highly scalable products may be installed as standalone or integrated to provide a single-vendor solution. For more information on Aspyra, its products and services, visit www.aspyra.com.
Safe Harbor Statement
This press release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to anticipated revenues, expenses, earnings, operating cash flows, the outlook for Aspyra's markets and the demand for its products. Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statement. Such statements are based upon, among other things, assumptions made by, and information currently available to, management, including management's own knowledge and assessment of the company's industry and competition. Factors that could cause Aspyra's actual results to differ materially from these forward-looking statements include among others: whether the combined company will realize the potential benefits of the merger; the competitive environment; unexpected technical and marketing difficulties inherent in major product development efforts; the potential need for changes in our long-term strategy in response to future developments; future advances in clinical information technology and procedures, as well as potential changes in government regulations and healthcare policies; and rapid technological change in the microelectronics and software industries. The company refers interested persons to its most recent Annual Report on Form 10-KSB and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The company assumes no duty to update its forward-looking statements.
The Aspyra, Inc. company logo is available at: http://www.primezone.com/newsroom/prs/?pkgid=2328